Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Enzymatic Asymmetric Reductive Amination. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN119913221A reveals enzymatic route for ACEI intermediates. Offers high stereoselectivity and cost reduction in pharmaceutical intermediate manufacturing supply chains.
Patent CN113106078B reveals novel LaLeuDH mutants enabling 1.5M substrate tolerance and coenzyme-free synthesis, offering significant cost reduction in pharmaceutical intermediate manufacturing.